21 Dec Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.
Posted at 10:06h
in
Secrest MH, Platt RW, Dormuth CR, Chateau D, Targownik L, Nie R, Doyle CM, Dell’Aniello S, Filion KB. Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:26-34.